Down-regulation of CK2 activity results in a decrease in the level of cdc25C phosphatase in different prostate cancer

Carolin C Schneider1, Claudia Götz, Andrea Hessenauer

  • 1Medizinische Biochemie und Molekularbiologie, Universität des Saarlandes, Gebäude 44, 66421 Homburg, Germany.

Insights

Protein kinase CK2 (CK2) regulates the cell cycle and has anti-apoptotic functions. Inhibiting CK2 reduces cdc25C levels and induces apoptosis, but cdc25C down-regulation is not required for this cell death.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Protein kinase CK2 (CK2) plays a role in cell cycle regulation and possesses anti-apoptotic properties.
  • The precise link between CK2's cell cycle and apoptotic functions remains unclear.
  • CK2 is known to phosphorylate cdc25C, a key protein in cell cycle progression.

Purpose of the Study:

  • To investigate the role of CK2 in regulating cdc25C levels and its connection to apoptosis.
  • To determine if cdc25C down-regulation is a necessary step for CK2 inhibition-induced apoptosis.

Main Methods:

  • Inhibition of CK2 activity using three distinct chemical inhibitors.
  • Inhibition of CK2 activity via transfection with a dominant-negative CK2α subunit.
  • Assessment of apoptosis through PARP cleavage and γH2AX phosphorylation.

Main Results:

  • Inhibition of CK2 activity consistently led to a decrease in cdc25C protein levels.
  • Down-regulation of cdc25C was observed following inhibition of CK2α, but not CK2α'.
  • Apoptosis, evidenced by PARP cleavage and increased γH2AX phosphorylation, occurred in both inhibition scenarios.

Conclusions:

  • Down-regulation of cdc25C is not a prerequisite for CK2 inhibition-induced apoptosis.
  • CK2 activity influences both cell cycle progression (via cdc25C) and apoptosis, but these pathways are not strictly dependent on each other for induction of cell death.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...